"There are gaps and significant variation" in the use of evidence-based, guideline-recommended therapies in patients with heart failure

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1608, 2007-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increasing adherence to guideline-recommended therapies is associated with decreased mortality in patients aged ≥ 90 years with acute coronary syndromes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 530, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Effectiveness of Guideline-Recommended Cardiac Drugs for Reducing Mortality in the Elderly Medicare Heart Failure Population: A Retrospective, Survey-Weighted, Cohort Analysis

By Richardson Diane M.  

Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. : 845-854

Adis International

Access to resources Recommend Favorite

Around two-thirds of adolescents with co-occurring psychiatric and substance use disorders did not receive guideline-recommended dual treatment

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 441, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Report on Evidence-Based Interventions: Recommended Next Steps

By Nelson Ron   Epstein Michael H.  

School Psychology Quarterly, Vol. 17, Iss. 4, 2002-12 ,pp. : 493-499

Guilford Publications Inc

Access to resources Recommend Favorite

Emerging therapies for heart failure

By Rudolph Amy E   McMahon Ellen G  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 247-258

Informa Healthcare

Access to resources Recommend Favorite